Figure 10.
The pharmacokinetic properties of eTGFBR2 (A) and HSA-eTGFBR2 (B). Serum concentrations of eTGFBR2 and HSA-eTGFBR2 at different time points were determined after intravenous injection in C57BL/6 mice (n = 3).
The pharmacokinetic properties of eTGFBR2 (A) and HSA-eTGFBR2 (B). Serum concentrations of eTGFBR2 and HSA-eTGFBR2 at different time points were determined after intravenous injection in C57BL/6 mice (n = 3).